MedTrace Logo

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

NCT01644513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2013-02-12

No results posted yet for this study

Summary

Patients with AMD who are being or have been treated with eye injections of drugs known as anti-VEGF agents with either good or poor response will have DNA collected with check swabs for analysis.

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

  • Center for Eye Research and Education

    collaborator UNKNOWN

  • Sequenom, Inc.

    lead INDUSTRY

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644513 on ClinicalTrials.gov